Related references
Note: Only part of the references are listed.Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection
Tae Yoo et al.
CANCER RESEARCH AND TREATMENT (2018)
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma
Andrea Ruzzenente et al.
SURGERY (2018)
Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?
Jun-Ke Wang et al.
ONCOTARGET (2017)
Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer
S. Yamashita et al.
BRITISH JOURNAL OF SURGERY (2017)
A New Clinically Based Staging System for Perihilar Cholangiocarcinoma
Roongruedee Chaiteerakij et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas
T. Ebata et al.
BRITISH JOURNAL OF SURGERY (2014)
Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma
Naru Kondo et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions
Bas Groot Koerkamp et al.
HPB (2014)
Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy
Tae Ryool Koo et al.
RADIATION ONCOLOGY JOURNAL (2014)
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
Werner Hartwig et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
The prognostic and predictive value of serum CA19.9 in pancreatic cancer
J. L. Humphris et al.
ANNALS OF ONCOLOGY (2012)
Preoperative Serum CA 19-9 Level as a Predictive Factor for Recurrence after Curative Resection in Biliary Tract Cancer
Moon Jae Chung et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
Naru Kondo et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies
Ioannis Hatzaras et al.
HPB (2010)
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial
William F. Regine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
Adam C. Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prognosis of perihilar cholangiocarcinoma: Hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus
Tsuyoshi Sano et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Altered expression of Lewis antigen on tissue and erythrocytes in gastric cancer patients
MJ Kim et al.
YONSEI MEDICAL JOURNAL (2002)
Share Paper
